CZCe Zong

Ce Zong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ce Zong has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Ke Zhang

    Department of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

    4 shared publications
  • Yuan Gao

    Department of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

    4 shared publications
  • Bo Song

    Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    3 shared publications
  • Hongbing Liu

    Department of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

    3 shared publications
  • Yusheng Li

    Department of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

    3 shared publications
  • Hongbing Liu

    Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    2 shared publications

Latest Publications

  • Open Access

    Nurse‐Led Identification of Financial Toxicity in Stroke Patients Using Machine Learning: Development and Validation of an Associational Prediction Model

    by Yuan Song, Yunjing Xing, Ce Zong, Hongbing Liu, Haixu Zhao, Yichang Liu, Fuze Zhang, Jiaqi Zhang, Ke Zhang, Changqing Sun, et al.

    Aim: To develop and validate a machine learning–based associational prediction model for nurse‐led identification of financial toxicity (FT) among stroke patients. Background: FT is increasingly recognized among patients with chronic conditions, yet evidence in stroke patients remains limited. Early identification may help nurses provide timely financial, psychosocial, and discharge‐related support. Methods: A total of 575 stroke patients were recruited. Based on Health Ecology Theory, factors were grouped into five levels. The dataset was randomly split 7:3 into training and test sets. Least Absolute Shrinkage and Selection Operator (LASSO) was applied for feature selection, and five machine learning models were trained and evaluated on the independent internal test set. The optimal model was interpreted using SHapley Additive exPlanations (SHAP) and evaluated in an external cross‐sectional validation dataset of 207 patients from another hospital. A web‐based calculator was developed for individualized FT assessment. Results: The prevalence of FT was 62.3%. The eXtreme Gradient Boosting (XGBoost) model demonstrated the best model performance, achieving an AUC of 0.823 in the internal test set and 0.865 in the external cross‐sectional validation set. SHAP analysis based on the XGBoost model identified age, fear of progression, complications, primary caregiver, and out‐of‐pocket cost as the most important associated factors of FT. A web‐based calculator based on the XGBoost model was further developed to support individualized FT assessment in nursing practice. Conclusions: The XGBoost model showed good internal and external performance in identifying FT among stroke patients. The web‐based XGBoost tool may support nurse‐led contemporaneous FT assessment in routine practice. Longitudinal validation is warranted to establish its clinical utility. Implications for Nursing Management: The tool may help nurse leaders embed structured FT assessment into admission and discharge workflows, enabling nurses to identify financially vulnerable stroke patients and initiate timely financial navigation, psychosocial support, and multidisciplinary referral.

  • Open Access

    Intravenous thrombolysis versus early antiplatelet therapy in acute ischaemic stroke with small artery occlusion

    by Ke Zhang, Hongbing Liu, Ce Zong, Yapeng Li, Kai Liu, Yusheng Li, Jing Yang, Bo Song, Yuming Xu, Yuan Gao

    Background: The efficacy of intravenous thrombolysis (IVT) versus early antiplatelet therapy (APT) in small artery occlusion (SAO) stroke remains debated. Methods: Ischaemic stroke (IS) patients with SAO who received IVT or early APT without IVT≤4.5 hours from stroke onset were screened from a prospective multicentre IS registry study from 1 January to 1 June 2021. The primary outcome was unfavourable functional outcome (FO) at 3 months. The secondary outcome was early neurological deterioration (END). The safety outcome was symptomatic intracerebral haemorrhage (sICH). Results: There were 1125 SAO patients with 394 receiving IVT. 411 patients (36.5%) exhibited unfavourable FO, and sICH occurred in 3 cases (0.27%), all in IVT group, at the follow-up. END was observed in 213 patients (18.9%). After propensity score matching and multivariable adjustment, IVT significantly reduced the likelihood of unfavourable FO at 3 months (aOR 0.447, 95% CI 0.305 to 0.656), but no significant difference was found in END (aOR 0.867, 95% CI 0.569 to 1.321). Clustering analysis identified two distinct phenotypes: phenotype 0 (characterised by traditional cardiovascular risk factors) and phenotype 1 (marked by prominent inflammatory markers). A significant treatment-by-phenotype interaction was observed (p=0.002), with a comparable magnitude of benefit in phenotype 0 (aOR 0.405, 95% CI 0.244 to 0.673) compared with phenotype 1 (aOR 0.414, 95% CI 0.218 to 0.783). Conclusion: IVT significantly reduced the likelihood of unfavourable FO at 3 months in SAO patients but did not significantly reduce END. Patients with traditional risk factors may benefit more from IVT than those with elevated inflammatory markers. Trial registration number: ChiCTR2100045258.


  • Open Access

    Serum fibrinogen/albumin ratio and early neurological deterioration in patients with recent small subcortical infarction

    by Haixu Zhao, Ying Yao, Ce Zong, Hongbing Liu, Ke Zhang, Yuan Song, Beizhu Ye, Jing Yang, Yusheng Li, Bo Song, et al.

    Serum fibrinogen/albumin ratio (FAR) is a new inflammatory marker related to a variety of diseases, and it has been shown to be associated with stroke. This study is to investigate the relationship between serum FAR and early neurological deterioration (END) in patients with recent small subcortical infarction (RSSI). Consecutive RSSI patients admitted to the First Affiliated Hospital of Zhengzhou University from June 2015 to June 2022 were enrolled. The National Institute of Health Stroke Scale (NIHSS) was utilized to evaluate the severity of the patients at admission and within seven days post-admission. END was defined as an increase of ≥2 points in NIHSS score from admission or ≥1 point in the motor item of the score within seven days post-admission. Multivariate logistic regression analysis was employed to identify risk factors for END. The correlation between FAR and END was investigated using restricted cubic spline (RCS) analysis. Subgroup analysis was used to assess stability across different populations. A total of 766 RSSI patients were included in the analysis, with 538 males (70.24%). END occurred in 115 (15.01%) patients. Multivariate logistic regression analysis revealed that FAR (OR = 1.016, 95%CI: 1.005-1.028), PAD (OR = 1.805, 95%CI: 1.161-2.807) and age (OR = 1.028, 95%CI: 1.009-1.048) were associated with END in RSSI patients. RCS analysis indicated a linear correlation between FAR and END (p for nonlinear = .128). Subgroup analysis indicated association between FAR and END in male (OR = 1.02, 95%CI: 1.00-1.03), patients aged ≤65 years (OR = 1.02, 95%CI: 1.00-1.03) and patients without smoking history (OR = 1.02, 95%CI: 1.00-1.03). Elevated FAR levels were associated with the occurrence of END within seven days after admission in RSSI patients, especially in men, age ≤65 years, or patients without smoking history.


  • Open Access

    Clinical features and associated factors of coexisting intracerebral hemorrhage in patients with cerebral small vessel disease: a cross-sectional study

    by Yuan Gao, Ce Zong, Hongbing Liu, Ke Zhang, Hongxun Yang, Yunchao Wang, Yusheng Li, Bo Song, Yuming Xu

    Intracerebral hemorrhage (ICH) is generally considered to be closely related to cerebral small vessel disease (CSVD), leading to a poor prognosis. However, the coexistence of ICH in general CSVD patients and related factors remain underreported. In our cross-sectional study, we screened 414 CSVD patients from a database at the Department of Neurology, First Affiliated Hospital of Zhengzhou University (September 2018 to April 2022). Imaging biomarkers of CSVD and coexisting ICH lesion were assessed. Factors associated with coexisting ICH in CSVD were determined using multivariate logistic regression analysis. ICH was observed in 59 patients (14.3%). Multivariate logistic regression showed that previous history of ischemic stroke or transient ischemic attack (OR 5.189, 95%CI 2.572–10.467, P < 0.001), high-grade perivascular space in the basal ganglia (n > 10) (OR 2.051, 95%CI 1.044–4.027, P = 0.037) and low adjusted calcium-phosphorus product (OR 0.728 per 1 [mmol/L]2 increase, 95%CI 0.531–0.998, P = 0.049) were associated with coexisting ICH in CSVD patients. The considerable proportion of coexisting ICH and revelation of associated factors in general CSVD patients alert physicians of the potential risk of the reoccurrence of ICH, and might have a significant impact on therapeutic strategies.


  • [The correlation between plasma heat shock proteins 90α levels and white matter hyperintensity in patients with cerebral small vessel disease].

    by W K Yu, Y C Wang, Y P Li, Y Gao, C Zong, Y M Xu, Y S Li

    Objective: To investigate the relationship between plasma heat shock proteins 90α(Hsp90α) levels and the white matter hyperintensity(WMH) in patients with cerebral small vessel disease(SVD). Methods: Patients admitted to the Department of Neurology, the First Affiliated Hospital of Zhengzhou University from March to August 2021 and diagnosed with WMH by magnetic resonance examination (MRI) were selected as the case group, matched with physical examination patients who visited the Department of Medical Examination during the same period and showed no WMH on MRI and no history of neurological diseases as the control group, and the level of plasma Hsp90α was quantitatively detected by enzyme-linked immunosorbent assay. Mann-Whitney U test was used to compare whether there was a difference in plasma Hsp90α levels between the control group and the case group.Multivariate logistic regression analysis was used to explore the related factors of WMH in patients with SVD. Results: Of the 183 subjects, the control group (n=73) consisted of 28 males and 45 females, aged (54±10) years, while the case group (n=110) consisted of 71 males and 39 females, aged (64±10) years old. Plasma Hsp90α level was higher in the case group than that of the control group [53.33(35.33, 70.09) ng/ml vs 35.02(18.51, 54.95) ng/ml, PP=0.002, OR=5.931, 95%CI:1.955-17.995). Conclusion: Higher level of plasma Hsp90α is associated with WMH in patients with SVD.

  • Prediction of Symptoms on Admission with Early Neurological Deterioration in Single Small Subcortical Infarct

    by Yuan Gao, Ce Zong, Hongbing Liu, Ke Zhang, Hongxun Yang, Anran Wang, Yunchao Wang, Hanghang Zhu, Yapeng Li, Kai Liu, et al.

    Background: Early neurological deterioration (END) often occurs during hospitalization in single small subcortical infarct (SSSI). While, symptoms on admission were rarely reported about its performance on predicting the risk of END. Objectives: The objective of this study is to explore the relationship between symptoms on admission and END in SSSI. Methods: Patients with SSSI in the lenticulostriate artery (LSA) territory presenting within 72 hours of stroke onset were screened prospectively. Clinical characteristics, including symptoms on admission, laboratory tests and imaging findings, were collected. Based on the body regions involved including spherical face (SF), upper limb (UL) or lower limb (LL), symptoms on admission were classified into single spherical face (sSF) and any involvement of limbs (AL). END was defined as ≥2 points increase in total National Institutes of Health Stroke Scale (NIHSS) score or ≥ 1 point increase in motor score within 72 hours after admission. Multivariate logistic regression was used to analyze factors associated with END. Results: Out of 5,832 ischemic stroke patients in the database, 394 patients were finally enrolled in analysis. 65 patients (16.5%) developed END. Multivariable logistic regression revealed that symptoms with LL (OR 2.337, 95% CI 1.041-5.246), UL (OR 2.936, 95% CI 1.349-6.390) were both associated with END, while the involvement of SF (OR 0.447, 95% CI 0.249-0.804) showed the opposite result. Further analysis found that symptoms with AL (OR 3.958, 95% CI 1.355-11.565) showed a higher risk of END compared to sSF after adjustment. Conclusion: Our results discovered that symptoms with AL carried a higher risk of END than those involving sSF in SSSI.